GSL: General Sales Licence
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet are: PL 17907/0157, PL 17907/0158.
Boots Aspirin 75 mg Gastro-Resistant Tablets (GSL)
Information for the user
Boots Aspirin 75 mg Gastro-resistant tablets
Read all of this leaflet carefully because it contains important information for you.
This medicine is available without prescription to treat minor conditions. However, you still need to take it carefully to get the best results from it.
What this medicine is for
This medicine belongs to a group of medicines called antiplatelet agents that help prevent blood cells sticking together.
It can be used to help prevent further heart attacks and strokes in patients who have had a history of these conditions. It can also be used after by-pass surgery.
It should not be used for pain relief or to reduce fever.
Before you take this medicine
This medicine can be taken by adults and children aged 16 years and over. However, some people should not take this medicine or should seek the advice of their pharmacist or doctor first.
If you are taking this medicine for the first time, talk to your doctor to make sure it is suitable for you.
Do not take:
Talk to your pharmacist or doctor:
Other important information
If you have surgery (even minor surgery such as tooth extraction) or any blood tests, tell your doctor or hospital staff that you are taking this medicine. If you get any unusual bleeding symptoms, talk to your doctor.
There is a possible association between aspirin and Reye’s syndrome when given to children. Reye’s syndrome is a very rare disease, which can be fatal. For this reason aspirin should not be given to children under the age of 16 years unless on the advice of a doctor.
You must immediately seek medical advice, if your symptoms get worse or if you experience severe or unexpected side effects e.g. unusual bleeding symptoms, serious skin reactions or any other sign of serious allergy (see section “Possible side effects”).
You should take care not to become dehydrated (you may feel thirsty with a dry mouth) since the use of Aspirin at the same time may result in deterioration of kidney function.
If you drink alcohol (wine, beer, spirits) when you are taking these tablets, it may make your stomach more sensitive to aspirin.
If you take other medicines
Before you take these tablets, make sure that you tell your pharmacist about ANY other medicines you might be using at the same time, particularly the following:
The effects of treatment may be influenced if aspirin is taken at the same time as other medicines for:
Before taking aspirin you should inform a healthcare professional about the medicines you are taking. If you are using aspirin regularly you should seek advice before taking any other medicine (including medicine you may have bought).
If you are unsure about interactions with any other medicines, talk to your pharmacist. This includes medicines prescribed by your doctor and medicine you have bought for yourself, including herbal and homeopathic remedies.
How to take this medicine
Check the foil is not broken before use.
If it is, do not take that tablet.
Adults of 16 years and over: take one or two tablets once a day
The usual dose for the long-term management of cardiovascular disease (disease affecting the blood supply to the heart) or cerebrovascular disease (disease affecting the blood supply to the brain) or following by-pass surgery is 1 to 2 tablets, once a day.
In some cases your doctor may advise you to take more tablets. In this case follow your doctor’s instructions.
Swallow the tablet whole with water. Do not cut, chew or crush the tablet.
Do not give to children under 16 years, unless your doctor tells you to.
Do not take more than the amount recommended above.
If you take too many tablets: Talk to a doctor straight away.
Possible side effects
Most people will not have problems, but some may get some.
If you get any of these serious side effects, stop taking the tablets. See a doctor at once:
If you get any of the following side effects see your pharmacist or doctor:
Common side effects
(may affect 1 to 10 people in 100)
Uncommon side effects
(may affect 1 to 100 people in 1000)
Rare side effects
(may affect 1 to 1000 people in 10,000)
Side effects with unknown frequency
(cannot be estimated from available data)
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.. By reporting side effects you can help provide more information on the safety of this medicine.
How to store this medicine
Do not store above 25°C.
Store in the original package.
Keep this medicine in a safe place out of the sight and reach of children, preferably in a locked cupboard.
Use by the date on the end flap of the carton.
What is in this medicine
Each gastro-resistant tablet contains Aspirin 75 mg, which is the active ingredient.
As well as the active ingredient, the tablets also contain potato starch, calcium hydrogen phosphate dihydrate (E341), microcrystalline cellulose (E460), talc (E553b), methacrylic acid-ethylacrylate-copolymer (containing sodium laurilsulfate, polysorbate 80), macrogol, simeticone.
The pack contains 28 or 56 white, circular tablets, plain on both sides.
Who makes this medicine
by the Marketing Authorisation holder
Leaflet prepared February 2020If you would like any further information about this medicine, please contact